Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420
Large-scale testing (Phase 3)Active Not RecruitingNCT04928807What this trial is testingShort-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)Who this might be right forRectal Cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 231
Testing effectiveness (Phase 2)Study completedNCT03085992What this trial is testingFolfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal CancerWho this might be right forRectal Cancer Azienda Ospedaliero, Universitaria Pisana 49
Testing effectiveness (Phase 2)UnknownNCT04524299What this trial is testingStudy of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 160
Testing effectiveness (Phase 2)Study completedNCT01781572What this trial is testingA Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant MelanomaWho this might be right forLocally Advanced or Metastatic NRAS Mutant Melanoma Pfizer 102
Early research (Phase 1)Study completedNCT01032681What this trial is testingEMD 521873 in Advanced Solid Tumors, MTD FindingWho this might be right forNon-Hodgkin Lymphoma Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Study completedNCT01593475What this trial is testingInduction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic CarcinomaWho this might be right forPancreatic Carcinoma Non-resectable National Cancer Center, Korea 44
Testing effectiveness (Phase 2)Study completedNCT02066675What this trial is testingTrabectedin First Line Therapy In Unfit Sarcoma StudyWho this might be right forMetastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to ReceiveStandard Chemotherapy Italian Sarcoma Group 24
Testing effectiveness (Phase 2)Looking for participantsNCT07457528What this trial is testingEfficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCCWho this might be right forResectable Esophageal Squamous Cell Carcinoma Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)Study completedNCT00060944What this trial is testingAssess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced CancerWho this might be right forLiposarcomaLeiomyosarcoma Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715931What this trial is testingPerioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaWho this might be right forAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionHER2-positive Gastric Cancer Yu jiren 30
Not applicableActive Not RecruitingNCT03255577What this trial is testingSentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast CancerWho this might be right forBreast CancerLocally Advanced Breast Cancer Memorial Sloan Kettering Cancer Center 162
Testing effectiveness (Phase 2)Looking for participantsNCT04901234What this trial is testingAdaptive RadioTherapy for OroPharynx CancerWho this might be right forOropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side Effect+2 more Centre hospitalier de l'Université de Montréal (CHUM) 120
Early research (Phase 1)Study completedNCT00747734What this trial is testingMNRP1685A in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Cancers Genentech, Inc. 35
Early research (Phase 1)UnknownNCT04906044What this trial is testingTotal Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal CancerWho this might be right forTislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT06172127What this trial is testingPHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast CancerWho this might be right forHER2-positive Breast Cancer MedSIR 165
Large-scale testing (Phase 3)Study completedNCT03337724What this trial is testingIpatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 579
Early research (Phase 1)Study completedNCT00543842What this trial is testingBevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerWho this might be right forRectal Cancer M.D. Anderson Cancer Center 19
Early research (Phase 1)Ended earlyNCT00955942What this trial is testingFlaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation TherapyWho this might be right forLung CancerRadiation Toxicity Abramson Cancer Center at Penn Medicine 48
Testing effectiveness (Phase 2)Study completedNCT05807542What this trial is testingNeoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCCWho this might be right forEsophagus Cancer Shanghai Zhongshan Hospital 20